Morph Labs builds differentiable protein structure prediction models fine-tuned on proprietary Australian pharmaceutical research datasets to accelerate structure-based drug design cycles. The Sydney team includes computational biologists from UNSW and is partnering with two local CROs for validation. Their edge is Australian regulatory familiarity and local biotech integration.